Heparan sulfate proteoglycan in Alzheimer's disease: aberrant expression and functions in molecular pathways related to amyloid-ß metabolism.

Ozsan McMillan, Ilayda; Li, Jin-Ping; Wang, Lianchun

Ozsan McMillan, Ilayda; Li, Jin-Ping; Wang, Lianchun.

Affiliation

Ozsan McMillan I; Department of Molecular Pharmacology & Physiology, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States.
Li JP; Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States.
Wang L; Department of Medical Biochemistry and Microbiology & The Biomedical Center, University of Uppsala, Uppsala, Sweden.

Am J Physiol Cell Physiol ; 324(4): C893-C909, 2023 04 01.

Article in En | MEDLINE | ID: mdl-36878848

Subject(s)

Alzheimer Disease; Mice; Animals; Alzheimer Disease/metabolism; Heparan Sulfate Proteoglycans/metabolism; Amyloid beta-Peptides/genetics; Amyloid beta-Peptides/metabolism; Heparitin Sulfate/metabolism; Brain/metabolism

Key words

Alzheimer's disease; amyloid-ß; expression; heparan sulfate proteoglycan; metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease Limits: Animals Language: En Journal: Am J Physiol Cell Physiol Journal subject: FISIOLOGIA Year: 2023 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google